Unlike prior studies of AMD development that were limited to patients with diabetes, the authors wrote in their paper, their findings suggest that GLP-1 drugs "may be associated with reduced risk even in individuals with obesity but not diabetes, potentially supporting a protective benefit independent of glycemic control and mitigating diabetes as a confounding factor.
Similar content being viewed by others Background Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are modified derivatives of glucagon-like peptide 1 (GLP-1) that simulate the regulatory effect of GLP-1 on blood glucose levels
To begin, you fill out a survey that asks questions about: Your biological sex Previous weight loss programs youve tried Your motivation to lose weight Your current weight and height Whether anyone in your family has struggled to lose weight If you have any health conditions, like high cholesterol, cancer, or sleep apnea If youve ever been diagnosed or treated with certain medical conditions, such as kidney problems, stroke, or eating disorders (such as anorexia or bulimia) If you take opioids, methadone, antipsychotics, or chemotherapies Based on your answers, Found either recommends its Rx Path or informs you that the Wellness Path isnt currently available but will be back soon
This helps increase your blood volume, which elevates blood pressure levels
FDA approval, if granted, is not expected before 2027
Step 2: Weekly Weight Loss Injections Quick once-a-week injections with dosing that gradually increases over time to allow your body to comfortably adjust to the medication
